Defunct Company
Total Trials
13
As Lead Sponsor
9
As Collaborator
4
Total Enrollment
660
NCT00254436
A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Weekly Procrit Given to Gastric or Rectal Patients
Phase: Phase 3
Role: Collaborator
Start: Oct 31, 2001
Completion: Jun 29, 2004
NCT01272986
Trial of Screening for ALOA-IgG AtheroAbzyme Test
Role: Lead Sponsor
Start: Jan 31, 2011
Completion: Mar 31, 2011
NCT01286909
Efficacy of Laflavon in Lowering Triglycerides and Raising High-Density Lipoprotein (HDL)
Completion: Jun 30, 2011
NCT01287182
Trial of Ateronon in Patients With Coronary Disease to Evaluate Its Effectiveness in Assessing the Risk Factors of Atherosclerosis
Start: May 31, 2011
Completion: Dec 31, 2011
NCT02517580
Vitamin K2 Supplementation and Arterial Stiffness in the Renal Transplant Population (The KING Trial)
Phase: Phase 2
Start: Mar 31, 2015
Completion: May 31, 2016
NCT03305536
Decalcification of the Aortic Valve by Vitamin K2 (Menaquinone-7)
Start: Jan 2, 2018
Completion: Dec 31, 2020
NCT05943457
Vitamin K2 Supplementation in Adult Episodic Migraine
Phase: N/A
Start: Sep 30, 2023
Completion: Dec 31, 2024